ATE212842T1 - Quinoxalin-derivate zur behandlung von tinnitus - Google Patents
Quinoxalin-derivate zur behandlung von tinnitusInfo
- Publication number
- ATE212842T1 ATE212842T1 AT96306764T AT96306764T ATE212842T1 AT E212842 T1 ATE212842 T1 AT E212842T1 AT 96306764 T AT96306764 T AT 96306764T AT 96306764 T AT96306764 T AT 96306764T AT E212842 T1 ATE212842 T1 AT E212842T1
- Authority
- AT
- Austria
- Prior art keywords
- tinnitus
- treatment
- quinoxaline derivatives
- medicament
- chem
- Prior art date
Links
- 208000009205 Tinnitus Diseases 0.000 title abstract 2
- 231100000886 tinnitus Toxicity 0.000 title abstract 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical class N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US521795P | 1995-10-10 | 1995-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE212842T1 true ATE212842T1 (de) | 2002-02-15 |
Family
ID=21714768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96306764T ATE212842T1 (de) | 1995-10-10 | 1996-09-18 | Quinoxalin-derivate zur behandlung von tinnitus |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5840723A (de) |
| EP (1) | EP0784973B1 (de) |
| JP (1) | JPH09132530A (de) |
| AT (1) | ATE212842T1 (de) |
| CA (1) | CA2187402C (de) |
| DE (1) | DE69619088T2 (de) |
| DK (1) | DK0784973T3 (de) |
| ES (1) | ES2168119T3 (de) |
| MX (1) | MX9604692A (de) |
| PT (1) | PT784973E (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9821179D0 (en) * | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
| FR2787028B1 (fr) * | 1998-12-15 | 2002-10-18 | Aventis Pharma Sa | Utilisation du riluzole dans le traitement des traumatismes acoustiques |
| US6362227B1 (en) * | 1999-03-02 | 2002-03-26 | Sepracor, Inc. | Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen |
| US6436449B2 (en) | 2000-03-02 | 2002-08-20 | Bo Gidlund | Use of a composition |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2123546T3 (es) * | 1991-11-15 | 1999-01-16 | Phafag Ag | Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras. |
| EP0542689B1 (de) * | 1991-11-15 | 1998-09-23 | Phafag Aktiengesellschaft | Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
-
1996
- 1996-09-18 DK DK96306764T patent/DK0784973T3/da active
- 1996-09-18 PT PT96306764T patent/PT784973E/pt unknown
- 1996-09-18 DE DE69619088T patent/DE69619088T2/de not_active Expired - Fee Related
- 1996-09-18 ES ES96306764T patent/ES2168119T3/es not_active Expired - Lifetime
- 1996-09-18 EP EP96306764A patent/EP0784973B1/de not_active Expired - Lifetime
- 1996-09-18 AT AT96306764T patent/ATE212842T1/de not_active IP Right Cessation
- 1996-10-08 JP JP8284569A patent/JPH09132530A/ja active Pending
- 1996-10-08 CA CA002187402A patent/CA2187402C/en not_active Expired - Fee Related
- 1996-10-09 MX MX9604692A patent/MX9604692A/es not_active IP Right Cessation
- 1996-10-09 US US08/728,111 patent/US5840723A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT784973E (pt) | 2002-06-28 |
| CA2187402A1 (en) | 1997-04-11 |
| DE69619088T2 (de) | 2002-07-11 |
| US5840723A (en) | 1998-11-24 |
| DK0784973T3 (da) | 2002-03-18 |
| CA2187402C (en) | 2000-08-08 |
| DE69619088D1 (de) | 2002-03-21 |
| ES2168119T3 (es) | 2002-06-01 |
| EP0784973B1 (de) | 2002-02-06 |
| MX9604692A (es) | 1998-04-30 |
| JPH09132530A (ja) | 1997-05-20 |
| EP0784973A2 (de) | 1997-07-23 |
| EP0784973A3 (de) | 1999-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY117896A (en) | Quinazoline derivatives | |
| SE9604786D0 (sv) | New compounds | |
| NO912410L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater. | |
| DE69623899D1 (de) | Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen | |
| DE69331171D1 (de) | Chinolin und Chinazolin Derivate zur Behandlung von Arthritis | |
| ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| DE69307674D1 (de) | HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS | |
| DE69419954D1 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| ATE250027T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| ATE186912T1 (de) | Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen | |
| ATE124259T1 (de) | Thiazolidine-2,4-dione für die behandlung der hypertonie. | |
| DE60005525D1 (de) | 2-aminotetraline zur behandlung von glaukom | |
| ATE136217T1 (de) | Verwendung von imino-derivaten von etianaldehyd zur herstellung eines arzneimittels zur behandlung des bluthochdrucks | |
| DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| DE69902142D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| DE3884878D1 (de) | Uricosuretische Zusammensetzung. | |
| DE69722630D1 (de) | Therapeutisches mittel zur behandlung von nierenerkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |